Bio Europe Content hub
Better Decisions. Bigger Impact. Outcomes That Matter.
Partnering with you to shape smarter pharma strategy and deliver meaningful patient impact.
Event Highlights
Hear from Evaluate’s experts at these BIO Europe panel discussions.
Piecing together the therapeutic landscape with analyst insights
Monday, 23 March 2026 13:30 - 14:15 | Room Sintra
Powered by leading analyst intelligence and data-driven insights, this session offers a comprehensive exploration of the evolving therapeutic landscape. Dive into emerging trends, market dynamics, and investment opportunities across key therapeutic areas, and uncover how shifting R&D pipelines, regulatory changes, scientific breakthroughs, and technological advancements are transforming the biopharma industry. Gain a forward-looking perspective on the most promising therapeutic areas and high-growth investment opportunities, equipping you with the strategic insights needed to navigate 2026 and beyond.
Daniel Chancellor - VP, Thought Leadership, Norstella
Charting the current of innovation and opportunity in oncology
Monday, 23 March 2026 14:30 - 15:15 | Room Sintra
Oncology continues to be a cornerstone of therapeutic innovation, with significant progress and emerging patterns reshaping the fight against cancer. This session will explore the latest advancements in oncology, from precision medicine and immunotherapies to novel modalities, combination treatments, and the use of alternative data points for pre-clinical development and clinical trial optimization. Experts will discuss the evolving investment landscape, strategies for navigating regulatory pathways, improving patient access, and fostering collaborations to accelerate innovation and create a brighter future for patients.
Ethan Smith - Director, Oncology, Norstella
Discover the uncharted waters of rare diseases
Monday, 23 March 2026 16:30 - 17:15 | Room Sintra
The rare disease space continues to be a frontier of unmet need and innovation. This session will convene leading voices to explore how scientific precision, strategic partnerships, capital, and novel business models are accelerating drug development. Through real-world insights, panelists will explore the critical role of patient-centric approaches in R&D and the use of real-world evidence, while addressing the complexities of clinical development, commercialization, and building sustainable pipelines in the face of regulatory, reimbursement, and patient access challenges. Discover what makes a rare disease company fundable today and the mindsets shaping the future of rare disease innovation and partnerships.
Ben Folwell - Director, BD&L Lead, Norstella
Diving into the depths of new frontiers in CNS
Tuesday, 24 March 2026 11:15 - 12:00 | Room Sintra
This session delves into the cutting-edge frontiers of CNS innovation and their potential to deliver transformative solutions for patients. Explore the latest breakthroughs in neurodegenerative diseases, psychiatric disorders, rare CNS conditions, and more. Engage in discussions on the challenges shaping the future of CNS research and development, including clinical advancements, patient access, and commercialization strategies, Ultimately, uncover the opportunities driving progress in the field and reimagine the future of CNS care.
Wen-Yu Huang - Therapy Area Director, Citeline
Meet the team
Connect with our team at booth #70 or through the partnering system at BIO-Europe.
Explore the advantages of partnering with Evaluate and understand how we can assist you in making critical strategic decisions during and after your participation at BIO-Europe with intelligence that powers your decisions.
Resources
Read our latest use‑cases and content that help BD teams strengthen strategy, validate opportunities, and shape decisions that truly matter.
Meet Evaluate at BIO Europe
Discover how we supercharge BD teams with the industry’s most trusted data, predictive insights, and expert consulting. From pinpointing high value assets and partners to validating commercial potential and strengthening your negotiation edge, we give you the clarity and confidence to move faster and secure better deals. Stop by to see how Evaluate can elevate your BD strategy and unlock your next opportunity.
Use Cases
How Evaluate Helps
Our experts will help you identify the tools and insights that support your strategic, commercial, or investment priorities.
Asset Screening
Benchmark Internal Forecasts with Consensus Forecasts
Screen and validate potential in‑licensing or acquisition assets by comparing internal views with trusted consensus forecasts to spot positive signals and red flags.
Focus on Specific Business Questions
Use the NPV Analyzer to project sales, peak revenue, and costs, identifying risks and opportunities to generate actionable recommendations.
Build and Inform Your Investment Strategy
Analyze markets, macrotrends, and companies to identify funding or acquisition targets early, assessing R&D risk and return from a single integrated view.
Company Profiling
Find Opportunities That Align With Your Strategy
Identify companies that match your objectives by evaluating their financials, strategic direction, and key upcoming milestones.
Track And Manage Your Targets
Build and manage target lists while assessing partnership openness and comparing phase‑level assets against competitors.
Defend And Validate Your Assumptions
Use robust tools and audited data to identify opportunities, reduce portfolio risk, and refine company profiles to maximize ROI.
Deal Benchmarking
Leverage Accurate Forecasts
Use transparent analyst‑driven forecasts and historical comparables to guide strategy, identify acquisition opportunities, and structure smarter deals.
Create Custom Benchmarks And Validate Internal Valuations
Benchmark competitor deal terms, including upfronts, milestones, and royalties—to validate internal valuations and understand true asset value.
Optimize Existing Workflows
Compare key metrics, validate assumptions, and streamline decisions using tailored intelligence powered by intuitive search and filtering.
Ready to see how Evaluate can help you make smarter decisions?
Get in touch with our team to explore the right solutions for your business.